291
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Effects of tobacco compound 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) on the expression of epigenetically regulated genes in lung carcinogenesis

, , ORCID Icon, , , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Priya Upadhyay, Ching-Wen Wu, Alexa Pham, Amir A. Zeki, Christopher M. Royer, Urmila P. Kodavanti, Minoru Takeuchi, Hasan Bayram & Kent E. Pinkerton. (2023) Animal models and mechanisms of tobacco smoke-induced chronic obstructive pulmonary disease (COPD). Journal of Toxicology and Environmental Health, Part B 26:5, pages 275-305.
Read now

Articles from other publishers (2)

Tengfei Bian, Haocheng Ding, Yuzhi Wang, Qi Hu, Sixue Chen, Naomi Fujioka, F Zahra Aly, Junxuan Lu, Zhiguang Huo & Chengguo Xing. (2022) Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin prophylaxis of NNK-induced lung carcinogenesis. Carcinogenesis 43:7, pages 659-670.
Crossref
Yuan Fang, Zhen Li, Hui Chen, Tongchao Zhang, Xiaolin Yin, Jinyu Man, Xiaorong Yang & Ming Lu. (2022) Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030. Journal of Cancer Research and Clinical Oncology.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.